Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol pharmacokinetics after oral and intravenous administration in elderly surgical patients
NL-OMON43207Withdrawn
- Sponsor
- Kennemer Gasthuis
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of haloperidol in delirium (2 arms), sponsored by Kennemer Gasthuis. Primary endpoint: Population pharmacokinetic model of haloperidol. Planned start Aug 2016; status: withdrawn.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON43207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43207.